PPT-Updates in Treatment of Hepatitis C

Gene LeSage MD FACP AGAF Objectives HCV epidemiology risk factors diagnosis and prognosis Interferon IFN and Ribavirin RBV based therapy Direct acting antiviral DAA therapies HCV Epidemiology. 10/23/12. Karla Thornton, MD, MPH. Division of Infectious Diseases. Department of Internal Medicine. UNM Health Sciences Center. kthornton@salud.unm.edu. Learning Objectives. Recognize the magnitude of the HCV epidemic and the consequences of not addressing the problem. Foundation for Faith Based Organizations. www.NYCHepBC.org. . Goals. To understand the liver and it’s role in the body. To understand liver health & disease. To understand Hepatitis C:. How it is Transmitted. Dr. Joanna Eveland, MS, MD. Clinical Chief for Special Populations, MNHC. O. bjectives. Understand recommendations for age cohort and risk based screening for Hepatitis C. Review strategies for health promotion and optimizing treatment readiness for HCV infected homeless individuals. HEPATITIS. Hepatitis. -Is inflammation of the liver. . (. itis. means inflammation and . Hepar. - Liver). Characterised. by irritation or swelling of liver cells(. hepatocytes. ). There are many forms of . . -Stacey . Trooskin. MD, PhD, Drexel University & . HepCAP. . -Karen Arendt, RN, St. Joseph's Center for Liver & Hepatobiliary Disease. -Courtney Jones, Patient Advocate Foundation. www.nvhr.org/program. Diana L. . Sylvestre. , MD. University of CA, San Francisco. OASIS Clinic, Oakland, CA. Disclosure Information. What’s New In Hepatitis C. Diana . Sylvestre. , MD. I have the following financial relationships to disclose:. Gene LeSage, MD, FACP, AGAF. Objectives. HCV epidemiology, risk factors, diagnosis and prognosis. Interferon (IFN) and Ribavirin (RBV) based therapy. Direct acting anti-viral . (. DAA) therapies. HCV Epidemiology. ASSOC. PROF. DR. INGRID MIRON. What is Viral Hepatitis ?. . Viral hepatitis is a systemic disease with primary inflammation of the liver by any one of a . heterogenous. group of . hepatotropic. viruses. : inflammation of liver; presence of inflammatory cells in organ tissue. . Pathogenesis: Immune response.. Acute Viral Hepatitis. : symptoms last less than 6 months. Chronic Hepatitis. : Inflammation of liver for at least 6 months. Rachel Stallings, MPH. March 4, 2020. Hepatitis . Hepatitis = inflammation of the liver. Can be self-limiting or progress to fibrosis (scarring), cirrhosis, or liver cancer. . Causes:. Most commonly caused by a virus, there are 5: A, B, C, D & E. 1 Theme Bringinghepatitiscare closer to you SOCO Politicalcommitment for sustained andsimplified hepatitis testing, prevention and treatment services in tegrated into p rimary health care servi . TODAY. DIAGNOSIS. TREATMENT. SPECIAL SITUATIONS. COMPLICATIONS. VACCINATION. DIAGNOSIS. Time since infection. Relative amount. HBsAg. Anti-HBs. IgM anti-. HBc. Total anti-. HBc. Serological patterns of acute HBV infection. Navigating Hepatitis C: . What Patients Need to Know . avigating. Hepatitis C: . What Patients Need to Know. Need to Know. HCV Screening. Bruce Burkett. Executive Director. HepC Alliance. Persons who have ever injected illegal drugs, including those who injected only once many years ago. Jocelyn James, MD. Assistant Professor, Department of Medicine. University of Washington. . Adapted from slides developed in collaboration with Judith . Tsui. and the Washington State Department of Health.